0001505318-16-000005.txt : 20161227 0001505318-16-000005.hdr.sgml : 20161226 20161227121520 ACCESSION NUMBER: 0001505318-16-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161227 DATE AS OF CHANGE: 20161227 EFFECTIVENESS DATE: 20161227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Therabron Therapeutics, Inc. CENTRAL INDEX KEY: 0001505318 IRS NUMBER: 261319238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-277047 FILM NUMBER: 162070097 BUSINESS ADDRESS: STREET 1: 9430 KEY WEST AVENUE, SUITE 125 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-205-7275 MAIL ADDRESS: STREET 1: 9430 KEY WEST AVENUE, SUITE 125 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Clarassance, Inc. DATE OF NAME CHANGE: 20101109 D 1 primary_doc.xml X0707 D LIVE 0001505318 Therabron Therapeutics, Inc. 9430 KEY WEST AVENUE, SUITE 150 ROCKVILLE MD MARYLAND 20850 240-205-7275 DELAWARE Clarassance, Inc. Corporation true Aprile L Pilon-Clayton c/o Therabron Therapeutics, Inc. 9430 Key West Avenue, Suite 150 Rockville MD MARYLAND 20850 Executive Officer Director Blanche M Johnson c/o Therabron Therapeutics, Inc. 9430 Key West Avenue, Suite 150 Rockville MD MARYLAND 20850 Director Todd Brady c/o Therabron Therapeutics, Inc. 9430 Key West Avenue, Suite 150 Rockville MD MARYLAND 20850 Director Jeffrey M Zell c/o Therabron Therapeutics, Inc. 9430 Key West Avenue, Suite 150 Rockville MD MARYLAND 20850 Director Eric Richman c/o Therabron Therapeutics, Inc. 9430 Key West Avenue, Suite 150 Rockville MD MARYLAND 20850 Director Vinzenz Ploerer c/o Therabron Therapeutics, Inc. 9430 Key West Avenue, Suite 150 Rockville MD MARYLAND 20850 Executive Officer Director Linda Chang c/o Therabron Therapeutics, Inc. 9430 Key West Avenue, Suite 150 Rockville MD MARYLAND 20850 Executive Officer Biotechnology Decline to Disclose 06b false 2016-12-12 false true true true true The underlying shares of common stock issuable upon conversion thereof. false 0 6045000 2325000 3720000 false 4 0 0 0 false Therabron Therapeutics, Inc. /s/ Linda Chang Linda Chang Chief Financial Officer 2016-12-27